Endothelin-1 but not endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease in Africa

Gene Regulation and Systems Biology

Volumn 2014, Issue 8, 2014, Pages 119-126

  Thakur, Tanya J ^a   Guindo, Aldiouma ^b   Cullifer, Londyn R ^a   Li, Yi ^c   Imumorin, Ikhide G ^d   Diallo, Dapa A ^b   Thomas, Bolaji N ^a  

^a ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

^b Centre de Recherche et Lutte Contre la Drépanocytose   (Mali)

^c SHANXI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^d Program on Infrastructure Policy   (United States)

Author keywords

Endothelial nitric oxide synthase; Endothelin 1; Pathophysiology; Polymorphisms; Sickle cell disease

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENOS GENE; ET 1 GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MALI; MUTANT; SICKLE CELL ANEMIA; WILD TYPE;

EID: 84901403392     PISSN: None     EISSN: 11776250     Source Type: Journal    
DOI: 10.4137/GRSB.S14836     Document Type: Article

References (49)

1. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10:e1001484.
2. Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31:289-93.
3. Modell B, Darlison M: Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480-7.
4. Weatherall DJ: The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115:4331-6.
5. Weatherall DJ: The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res. 2011;134:493-7.
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9.
7. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA: Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vasoocclusive sickle crisis. Blood. 1998;92:2551-5.
8. Hammerman SI, Klings ES, Hendra KP, Upchurch GR Jr, Rishikof DC, Loscalzo J: Endothelial cell nitric oxide production in acute chest syndrome. Am. J. Physiol. 1999;277:H1579-92.
9. Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA: Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 2000;22:515-20.
10. Hingorani AD: Polymorphisms in endothelial nitric oxide synthase and atherogenesis. John French Lecture 2001. Atherosclerosis. 2001;154:521-7.
11. Chaar V, Tarer V, Etienne-Julan M, Diara JP, Elion J, Romana M: ET-1 and ecNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Hematologica. 2006;91:1277-8.
12. Sharan K, Surrey S, Ballas S, Borowski M, Devoto M, Wang KF, et al. Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. British J Hematol. 2004;124:240-3.
13. Nishank SS, Singh MP, Yadav R, Gupta RB, Gadge VS, Gwal A: Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India. J Hum Genet. 2013;58:775-9.
14. Tanus-Santos JE, Desai M, Flockhart DA: Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001;11:719-25.
15. Marroni AS, Metzger IF, Souza-Costa DC, et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide. 2005;12:177-82.
16. Bolli P, Sticchi E, Abbate R, Fatini C: A novel allele of eNOS gene in the Italian population: The actual essence of intron 4 polymorphism. Nitric Oxide. 2007;3:392-4.
17. Serrano NC, Diaz LA, Casas JP, Hingorani AD, Moreno-De-Luca D, Paez MC: Frequency of eNOS polymorphisms in the Colombian general population. BMC Genetics. 2010;11:54.
18. Thomas BN, Thakur TJ, Yi L, Guindo A, Diallo DA, Ott JG: Extensive ethnogenomic diversity of endothelial nitric oxide synthase (eNOS) polymorphisms. Gene Reg Systems Biol. 2013;7:1-10.
19. Haynes WG, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344:852-4.
20. Piechota M, Banach M, Irzmanski R, et al. Plasma endothelin-1 levels in septic patients. J Intensive Care Med. 2007;22:232-9.
21. Figueras-Aloy J, Gomez L, Rodriguez-Miguelez JM, et al. Plasma nitrite/nitrate and endothelin-1 concentrations in neonatal sepsis. Acta Paediatrica. 2003;92:582-7.
22. Figueras-Aloy J, Gomez-Lopez L, Rodriguez-Miguelez JM, et al. Plasma endothelin-1 and clinical manifestations of neonatal sepsis. J Perinat Med. 2004;32:522-6.
23. Tharaux PL: Endothelin in renal injury due to sickle cell disease. Contrib Nephrol. 2011;172:185-99.
24. Lagoda G, Sezen SF, Hurt KJ, Cabrini MR, Mohanty DK, Burnett AL: Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J. 2014;28:1-9.
25. Teasuro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with Tartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000;97:2832-5.
26. Ekmekçi A, Ozcan KS, Güngör B, et al. The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease. Acta Cardiol. 2013;68:464-8.
27. Liu R, Geng P, Ma M, et al. Association between Endothelial nitric oxide synthase gene polymorphism (T-786C) and ischemic stroke susceptibility: A meta-analysis. Int J Neurosci. 2013.
28. Matsa LS, Rangaraju A, Vengaldas V, et al. Haplotypes of NOS3 gene polymorphisms in dilated cardiomyopathy. PLoS One. 2013;8:e70523.
29. Ramírez-Patiño R, Figuera LE, Puebla-Pérez AM, et al. Intron 4 VNTR (4a/b) Polymorphism of the Endothelial Nitric Oxide Synthase Gene Is Associated with Breast Cancer in Mexican Women. J Korean Med Sci. 2013;28:1587-94.
30. Vargas AE, deSilva MAL, Silla L, Chies JAB: Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. Tissue Antigens. 2005;66:683-90.
31. Gregoski MJ, Buxbaum SG, Kapuku G, et al. Interactive influences of ethnicity, endothelin-1 gene, and everyday discrimination upon nocturnal ambulatory blood pressure. Ann Behav Med. 2013;45:377-86.
32. Lind JM, Hutcheson HB, Williams SM, et al. Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet. 2007;120:713-22.
33. Sakai T, Shikishima K, Matsushima M, Tsuneoka H: Genetic polymorphisms associated with endothelial function in nonarteritic anterior ischemic optic neuropathy. Mol Vis. 2013;19:213-9.
34. Saini V, Bhatnagar MK, Bhattacharjee J: Association of endothelial dysfunction with endothelin, nitric oxide and eNOS Glu298Asp gene polymorphism in coronary artery disease. Dis Markers. 2011;31:215-22.
35. Tousoulis D, Toli E, Miliou A, et al. The impact of G5665T polymorphism of endothelin-1 gene, on endothelin-1 levels and left ventricular function in ischemic heart disease. Int J Cardiol. 2013;168:1568-9.
36. Gilliland F: Ethnic differences in cancer incidence: A marker for inherited susceptibility? Environ. Health Persp. 1997;105:897-900.
37. Kittles RA, Chen W, Panguluri RK, et al. CYP3A4-V and prostate cancer in African Americans: Causal or confounding association because of population stratification? Hum Genet. 2002;110:553-60.
38. Kalinowski L, Dobrucki IT, Malinski T: Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511-7.
39. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE: Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis. 2006;186:428-32.
40. Lind L, Syvänen AC, Axelsson T, Lundmark P, Hägg S, Larsson A: Variation in genes in the endothelin pathway and endothelium-dependent and endothelium-independent vasodilation in an elderly population. Acta Physiol (Oxf). 2013;208:88-94.
41. Lao O, Vallone PM, Coble MD, et al. Evaluating self-decared ancestry of US American with autosomal, Y-chemosomal and mitochondrial DNA. Hum Mutation: Mutation in Brief. 2010;31:E1875-93.
42. Gelpi AP. Migrant populations and the diffusion of the sickle cell gene. Ann Intern Med. 1973;79:258-64.
43. Kulozik AE, Wainscoat JS, Serjeant GR, Kar BC, Al-Awamy B, Essan GJ, et al. Geographical survey of beta S-globin gene haplotypes: Evidence for an independent Asian origin of sickle-cell mutation. Am J Hum Genet. 1986;39:239-44.
44. Chui DH, Dover GJ. Sickle cell disease: No longer a single gene disorder. Curr Opin Pediatr. 2001;13:22-7.
45. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343-60.
46. Morris CR: Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology. 2008;177-85.
47. Thomas BN, Petrella CR, Thakur TJ, Crespo SR, Diallo DA: Genetic polymorphism of Plasmodium falciparum merozoite surface protein-1 and 2 and diversity of drug resistance genes in blood donors from Bamako, Mali. Infectious Diseases: Research and Treatment. 2012;6:49-57.
48. Terwilliger JD, Ott J: Handbook of human genetic linkage. Baltimore: Johns Hopkins University Press; 1994.
49. Makani J, Williams TN, Marsh K (2007). Sickle cell disease in Africa: Burden and research priorities. Ann Trop Med Parasitol. 2007;101:3-14.